BIOLIFE SOLUTIONS INC - Form 4 Filing

This SEC filing (Form 4) details a transaction by Mathew Aby J., EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC. On June 8, 2026, Mr. Mathew disposed of 627 shares of Common Stock, with a price of $26.10 per share. This transaction was made to satisfy tax withholding obligations arising from the release of restricted stock units. Following this transaction, Mr. Mathew holds 389,540 shares of BIOLIFE SOLUTIONS INC. common stock.